35 related articles for article (PubMed ID: 7057256)
21. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
Mäenpää H
Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
[TBL] [Abstract][Full Text] [Related]
22. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
23. [Radioiodine therapy in differentiated thyroid gland carcinoma].
Schicha H; Dietlein M
Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
[TBL] [Abstract][Full Text] [Related]
24. [Is radioiodine ablation of residual thyroid tissue indicated after an operation for differentiated thyroid cancer?].
Chebotareva ED; Shishkina VV
Lik Sprava; 1997; (1):118-22. PubMed ID: 9221132
[No Abstract] [Full Text] [Related]
25. [The external radiotherapy of differentiated thyroid carcinoma].
Sautter-Bihl ML; Heinze HG
Dtsch Med Wochenschr; 1992 Apr; 117(17):665-8. PubMed ID: 1369745
[No Abstract] [Full Text] [Related]
26. [Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out].
Koch W; Knesewitsch P; Tatsch K; Hahn K
Nuklearmedizin; 2003 Feb; 42(1):10-4. PubMed ID: 12601448
[TBL] [Abstract][Full Text] [Related]
27. Treatment with unsealed radioisotopes.
Greig WR; McDougall IR; Halnan KE
Br Med Bull; 1973 Jan; 29(1):63-8. PubMed ID: 4598450
[No Abstract] [Full Text] [Related]
28. External beam radiotherapy in thyroid carcinoma: clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group.
Mangoni M; Gobitti C; Autorino R; Cerizza L; Furlan C; Mazzarotto R; Monari F; Simontacchi G; Vianello F; Basso M; Zanirato Rambaldi G; Russi E; Tagliaferri L
Tumori; 2017 Mar; 103(2):114-123. PubMed ID: 27647221
[TBL] [Abstract][Full Text] [Related]
29. Treatment of medullary carcinoma of the thyroid with I-131.
Nusynowitz ML; Pollard E; Benedetto AR; Lecklitner ML; Ware RW
J Nucl Med; 1982 Feb; 23(2):143-6. PubMed ID: 7057256
[TBL] [Abstract][Full Text] [Related]
30. Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ
Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
[TBL] [Abstract][Full Text] [Related]
31. Radioiodine therapy in differentiated thyroid carcinoma.
Salvatori M; Rufini V; Garganese MC; Di Giuda D
Rays; 2000; 25(2):221-38. PubMed ID: 11370540
[TBL] [Abstract][Full Text] [Related]
32. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
[TBL] [Abstract][Full Text] [Related]
33. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
34. The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
De Klerk JM; Oyen WJ
Minerva Endocrinol; 2009 Mar; 34(1):57-69. PubMed ID: 19209128
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
